有效的耐火期个性化对患者特异性心律失常计算机模型中的心律失常脆弱性的影响
Patricia Martínez Díaz1, Albert Dasí2, Christian Goetz1,3
1Department of Electrical Engineering and Information Technology, Institute of Biomedical Engineering, Karlsruhe Institute of Technology (KIT), Fritz-Haber, Weg 1 30.33, 76131, Karlsruhe, Germany.
概括
用患者特定的有效耐火期 (ERP) 测量来个性化心房模型显著影响心律失常的脆弱性. 这种方法对于心脏病学中精确的in silico建模至关重要.
科学领域:
- 计算电生理学 计算电生理学
- 心脏建模的心脏建模
- 节律失常机制 节律失常机制
背景情况:
- 有效耐火期 (ERP) 是一个关键的电生理学属性,影响心律失常.
- 患者特有的心房计算模型对于临床决策有价值,但很少包含个性化的ERP.
- 缺乏ERP个性化限制了in silico心房模型在预测心律不整的脆弱性方面的准确性.
研究的目的:
- 评估将临床ERP测量整合到个性化的in silico心房模型中的影响.
- 评估个性化的ERP数据如何影响心律不整的脆弱性和心跳动脉周期长度.
- 在患者特异性心房模型中比较ERP分布的不同建模方法.
主要方法:
- 从七名患者获得了临床ERP测量结果,来自多个心房位置.
- 使用电解剖学绘图数据创建了个性化的心房解剖模型.
- 库特曼切细胞模型被调整为复制患者特定的ERP,比较同质,异质,区域和连续ERP分布.
主要成果:
- 个性化建模场景 (区域和连续ERP) 与非个性化场景 (3.4%和7.7%) 相比,显示出更高的心律失常脆弱性 (9.0%和7.0%).
- 个性化模型也比非个性化模型产生了更长的心动节拍周期长度 (265.2毫秒和285.9毫秒).
- 高达20ms的ERP测量不确定性对模型漏洞的影响很小.
结论:
- 使用患者特定的ERP进行心房内模型的电生理学个性化对于准确的心律失常脆弱性评估至关重要.
- 增加ERP分散显著影响重新进入的动态.
- 为了确认这些发现,需要在更大的患者队伍中进一步验证.
相关概念视频
01:28Mechanism of Cardiac Arrhythmias
901
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
901
01:28Disturbances in Heart Rhythm
922
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
922
01:30Cardiac Action Potential
1.1K
Cardiac action potentials are essential for proper heart function, enabling the rhythmic contractions needed for adequate blood circulation. Nodal cells and Purkinje fibers, specialized for electrical conduction, generate these action potentials.
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
1.1K
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
719
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
719
01:20Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
799
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
799
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
936
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
936